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Background: There are limited data on the prevalence of depressive symptoms in hospitalised elderly HF patients and demographic and
clinical characteristics associated with depressive symptoms are not known.
Methods: A sample of 572 HF patients (61% male; age 71T12 years; LVEF 34%T15) was recruited from 17 Dutch hospitals during HF
admission. Depressive symptoms were assessed by the CES-D. Demographic, clinical variables and HF symptoms were collected from
patient chart and interview.
Results: Forty one percent of the patients had symptoms of depression with women significantly more often reporting depressive symptoms
than men 48% vs. 36% (v2=8.1, p <0.005). HF patients with depressive symptoms reported more clinical HF symptoms than patients
without depressive symptoms. Even after deleting HF related symptoms (sleep disturbances and loss of appetite) from the CES-D scale, 36%
of patients were still found to have symptoms of depression. Multivariable logistic regression analyses revealed that depressive symptoms
were associated with female gender (odds 1.68, 95% CI 1.14–2.48), COPD (odds 2.11, 95% CI 1.35–3.30), sleep disturbance (odds 3.45,
95% CI 2.03–5.85) and loss of appetite (odds 2.61, 95% CI 1.58–4.33).
Conclusions: Depressive symptoms are prominent in elderly hospitalised HF patients especially in women. Depressive symptoms are
associated with more pronounced symptomatology, despite the fact that other indices of severity of left ventricular dysfunction are similar.
D 2005 European Society of Cardiology. Published by Elsevier B.V. All rights reserved.Keywords: Heart failure; Depressive symptoms; Elderly patients; Symptoms of heart failure1. Introduction
Despite advances in medical treatment, the prognosis of
heart failure (HF) remains poor [1]. HF is a chronic disease,
which may confront patients with numerous threats includ-
ing impaired physical functioning and changes in future
perspectives. Response to this can be emotional disbalance
and depression. Studies that have reported on the prevalence
of depression in HF patients mostly evaluate the risk on1388-9842/$ - see front matter D 2005 European Society of Cardiology. Publish
doi:10.1016/j.ejheart.2005.11.010
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(I. Lesman-Leegte).morbidity and mortality [2–5]; however, only a few studies
have investigated the relation between patient or clinical
characteristics and depressive symptoms. The few studies
that have investigated the demographic and clinical factors
related to depressive symptoms have used various diagnos-
tic tools for assessing depressive symptoms. The Beck
Depression Inventory scale (BDI) is most often used in
these studies. The BDI is known to focus substantially on
somatic items and therefore may be inadequate as an
instrument to screen for depressive symptoms in HF patients
[2]. In some studies, the Center for Epidemiological
Depression Scale (CES-D) is used. It has only two somatic
items that are similar to the somatic symptoms in HF
patients and is therefore a reliable and well-validatedilure 8 (2006) 634 – 640ed by Elsevier B.V. All rights reserved.
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patients. [3–7]. The studies describing depressive symp-
toms in HF have used relatively small sample sizes and
rather young patient samples: the mean age in most studies
was below 65 years of age. Focusing on these Frelatively
young_ patients may not be representative for the present
Freal life_ HF population. Finally most of the studies about
HF and depression or depressive symptoms were performed
in the United States [4,5,8–14]; only a few have been
performed in Europe [15–17].
It is hard to diagnose depression in diseases in which
symptoms of the disease are similar to symptoms of
depression [18]. In HF patients, symptoms like fatigue,
sleeplessness, loss of appetite, feelings of worthlessness and
low energy are common. The same symptoms are used to
diagnose depression [19]. This is why it is difficult to
distinguish depressive symptoms from worsening HF.
To carefully look at symptoms of depression in HF
patients we assessed the occurrence of depressive symptoms
in hospitalised, elderly HF patients and explored related
demographic and clinical factors.
More specifically the following research questions are
addressed:
& What is the prevalence of depressive symptoms in elderly
hospitalised HF patients?
& Which demographic and clinical variables are related to
depressive symptoms in elderly hospitalised HF patients?
& What is the relationship between depressive symptoms
and symptoms of HF?
2. Methods
2.1. Participants
Patients in the present study were included in a multi
centre HF trial (Coordinating study evaluating Outcomes
of Advising and Counselling in HF patients—COACH)
conducted in the Netherlands [20]. Data on depressive
symptoms that are reported in this study were collected
from baseline interviews, before any intervention took
place. The study design has been described elsewhere
[20]. A summary of the inclusion and exclusion criteria
used, is as follows. All patients were admitted for HF
(NYHA II–IV). Patients were at least 18 years of age,
with evidence of structural underlying heart disease.
Patients were excluded if they were enrolled in a study
requiring additional visits to research health care person-
nel. Other reasons for exclusion were invasive interven-
tion within the last 6 months (PTCA, CABG, HTX, valve
replacement) or planned during the following 3 months;
being in the end stage of another life threatening disease
or having a psychiatric diagnosis. In total, 572 patients (of
the included 737 patients) having complete data sets of
CES-D and HF symptoms were included in the analysis.The Central Ethics Committee approved the study and
prior to the announcement of the investigation all patients
provided written informed consent. The investigation




The definition of depressive symptoms used in this study
is taken from the fourth edition of the Diagnostic and
Statistical Manual of Mental Disorder-Fourth Edition
(DSM-IV) [14,19]. Depression due to a general medical
condition (e.g. heart failure), is defined as: patient’s clinical
presentation which is dominated by a mood disorder that
persists and is characterized by either or both depressed
mood or markedly decreased interest or pleasure in nearly
all activities, or mood that is elevated, expansive or irritable
[14,19].
The Center for Epidemiological Studies Depression
Scale (CES-D) was used to assess depressive symptoms of
the patients under investigation. The CES-D is a 20-item
self-report questionnaire designed to measure depressive
symptomatology in the general population and in the
medically ill [6,7]. The scale is purported to measure the
presence of depressive mood by asking respondents to rate
how often they have experienced each of the 20 symptoms
during the past week. Each item is scored on a four-point
scale: (0) Frarely or non of the time_ (less than once a week),
(1) Fsome or a little of the time_ (1–2 days of the week), (2)
Foccasionally or a moderate amount of time_ (3–4 days a
week), or (3) Fmost or all of the time_ (5–7 days a week).
The total score for a respondent consists of a sum score to
the responses to all 20 items, ranging from 0 to 60, with
higher scores indicating more symptoms of depression
(weighted by the occurrence during the past week.) A cut-
off point of 16 is generally used to define patients who are at
risk for clinical depression [3,21]. The CES-D is a valid
instrument to identify high-risk groups and to study the
relationships between depressive symptoms and many other
variables, which has been established in cardiac and non-
cardiac patients [23,24,26].
2.2.2. Demographic and clinical data
During admission to the hospital, data on demographics:
age, sex, living situation and educational level were
collected from patient interview. Left ventricular ejection
fraction (LVEF), NYHA functional class at admission,
aetiology, duration of HF and the presence of co-morbidities
(hypertension, COPD, Type II diabetes mellitus, peripheral
vascular disease, renal dysfunction, arthritis and cerebro-
vascular accident) was collected from medical records.
2.2.3. Symptoms of HF
Symptoms of HF were assessed from an interview
comprising ten structured questions. During this interview,
Table 1
Patient characteristics and univariate differences between patients with and without depressive symptoms
Total group No depressive symptoms Depressive symptoms P value
n =572 n =339 n =233
MeanT sd MeanT sd MeanT sd
Demographics
Age 71T12 71T12 70T12 0.16
Sex (female) 38% 52% 48% 0.004*
Living with a partner 61% 62% 57% 0.24
Education level
At least six years of primary school 55% 55% 55% 0.77
Diploma secondary school 30% 28% 32%
Higher education or university 15% 16% 13%
Clinical characteristics
LVEF (%) 34T15 33T14 34T15 0.52
LVEF <40% 32% 71% 63% 0.07
NYHA II, III, IV (at admission %) 6, 51, 43 6, 50, 44 6, 52, 42 0.60
Serum creatinine (mmol/L) 122T45 120T41 124T50 0.31
Serum sodium (mmol/L) 139T4 139T4 139T5 0.24
Haemoglobin (mmol/L) 8.3T1.2 8.4T1.2 8.3T1.2 0.49
Aetiology (%)
Ischaemic 43% 45% 40% 0.24
Non-ischaemic 57% 55% 60%
Atrial fibrillation 42% 42% 43% 0.89
Medication at admission
Diuretics 62% 62% 62% 0.89
ACE-inhibitors/ARB 56% 55% 56% 0.85
Beta blockers 42% 41% 43% 0.58
Digoxin 19% 17% 21% 0.18
Spironolactone 16% 15% 17% 0.50
Comorbidities
Hypertension 35% 33% 39% 0.14
COPD 25% 22% 29% 0.06
Diabetes mellitus II 20% 20% 19% 0.79
Peripheral vascular disease 16% 16% 18% 0.60
Renal dysfunction 8% 8% 8% 0.95
Cerebrovascular accident 8% 8% 8% 0.95
Arthritis 7% 5% 9% 0.14
Mean number of comorbidities 1.1T1.0 1.0T1.0 1.2T1.1 0.16
No comorbidities 34% 36% 31%
1–2 comorbidities 56% 54% 59%
2–6 comorbidities 10% 10% 10%
Duration of heart failure (y) 2.5T4.8 2.8T5.6 2.0T3.3 0.19
Heart failure symptoms
Mean number of HF symptoms 4.0T1.3 3.9T1.3 4.6T1.4 0.0001*
No symptoms 2% 0.3% 0.4%
1–2 symptoms 10% 14% 5.4%
3–4 symptoms 41% 48% 30%
5–6 symptoms 47% 37% 66%
Dyspnoea 95% 93% 97% 0.017
Fatigue 87% 82% 95% 0.0001*
Coughing 70% 68% 73% 0.17
Oedema 64% 62% 67% 0.20
Sleep disturbance 62% 51% 79% 0.0001*
Loss of appetite 51% 40% 68% 0.0001*
Depression
Mean CES-D total score (range: 0–60) 15.6T11 8T4.5 26T8.3 0.0001*
Symptoms of depression (CES-D16) 41%
I. Lesman-Leegte et al. / European Journal of Heart Failure 8 (2006) 634–640636
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Fig. 2. Number of patients (n =572) with sleep disturbance and loss of
appetite among the 4 quartiles of the CES-D score.
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following symptoms during the last month: ankle oedema
during the day, ankle oedema when getting out of bed in the
morning, sleep disturbance, fatigue, breathlessness at rest
and during exertion, orthopnoea, coughing, dry cough or
loss of appetite. These ten symptoms were clustered in six
symptom indexes: oedema, sleep disturbance, fatigue,
dyspnoea, coughing and loss of appetite. A total HF
symptom score was obtained from the sum of the six
symptom indexes.
2.3. Statistical analyses
Descriptive statistics were used to characterize the study
population. Means, medians and standard deviations are
presented for depressive symptoms, demographic and
clinical data and HF symptoms (Table 1).
Student’s t-tests and Mann Whitney tests for continu-
ous variables and chi square tests for categorical variables
were performed to compare demographic and clinical
characteristics and HF symptoms between patients with or
without depressive symptoms. A multivariable logistic
regression analysis was utilized to define the independent
association between depressive symptoms and demograph-
ic and clinical characteristics and HF symptoms. The
multivariate model was built by entering those variables
that had a univariate p value <0.15 (e.g. sex, LVEF,
hypertension, COPD, arthritis, number of HF symptoms,
dyspnoea, fatigue, sleep disturbance and loss of appetite)
and retaining those variables with p <0.05 in the final
model.3. Results
3.1. Participants
Between November 2002 and April 2004, 737 patients
who met the criteria for the COACH study, agreed toFig. 1. CES-D total score in population (n =572).participate and gave informed consent. Six hundred and
eighty one of these patients filled out the CES-D
questionnaire; however, 109 of these patients did not
complete the structured interview about the ten HF
symptoms. Therefore, 572 HF patients were included in
this sub-study. There were no significant differences in
basic demographics (age, sex) and clinical variables (LVEF,
NYHA class) between patients with or without complete
data sets.
On average, patients were 71T12 years of age and most
patients (62%) were male (Table 1). The majority of patients
had a low educational level, were living with a partner and
had suffered from HF for more than two and a half years.
On admission, most patients were in NYHA functional class
III (51%) and IV (43%). The mean LVEF was 34%T15. On
average, patients had one medical comorbidity (range 0–6).
One third of patients were hypertensive (35%), Chronic
Obstructive Pulmonary Disease was present in 25% of the
patients and type II diabetes mellitus in 20%. All patients
were on standard medical treatment regimens with ACE-
inhibitors, beta blockers and diuretics.
3.2. HF symptoms
Patients reported on average four symptoms of HF; less
than two percent of the patients reported no symptoms, 30%
had five symptoms and 17% had six symptoms of HF at the
time of measurement. The most frequently reported symp-
toms of HF were dyspnoea (95%) and fatigue (87%). More
than two thirds of the patients had cough, oedema and sleep
disturbance. Fifty one percent of patients had loss of
appetite (Table 1).
3.3. Prevalence of depressive symptoms
The mean total score on the CES-D in this study
population was 15.6T11 (0–60) (Fig. 1). More than 41%
of the patients had depressive symptoms (score CES-
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significant differences were found between patients with
and without depressive symptoms, including the somatic
items like loss of appetite and sleep disturbance.
Loss of appetite and sleep disturbance are two common
somatic symptoms in HF patients as well as in patients with
depression. Of the non-depressed HF patients 40% reported
loss of appetite and 51% have sleeping difficulties. But
patients with depressive symptoms more often report loss of
appetite (68%) and sleeping difficulties (79%) (Table 1).
Although sleep disturbance and loss of appetite are both
symptoms of HF and symptoms of depression, patients with
depressive symptoms score significantly worse on these two
items (Fig. 2). When these two items were removed from
the CES-D, 36% of the HF patients still reported depressive
symptoms (CES-D16).
3.4. Differences in demographic and clinical characteristics
between patients with and without depressive symptoms
Based on the CES-D score we compared patients without
(score <16) or with (score 16) depressive symptoms.
Univariate analyses among patients with or without depres-
sive symptoms indicated that more women than men
suffered from depressive symptoms: 48% versus 36%
(v2=8.1, p <0.05) (Table 1). No significant differences
were found between patients with and without depressive
symptoms according to age, living with a partner and
educational level.
With respect to clinical characteristics, like LVEF,
NYHA functional class at admission, aetiology, duration
of HF and the number and nature of medical co-morbidities,
no significant differences were seen between the two groups
(Table 1).
3.5. Relation between depressive symptoms and HF
symptoms
Compared to patients without depressive symptoms,
patients with depressive symptoms had more symptoms of
HF (z =7.1 p <0.01). Also the nature of these symptoms
was different between the two groups. Patients with
depressive symptoms more often reported dyspnoea
( p <0.01), fatigue, sleep disturbance and loss of appetite
( p <0.01). In a multivariable logistic regression analysis
female sex, COPD, sleep disturbances and loss of appetiteTable 2
Summary statistics for multivariable logistic regression model of depressive
symptoms and demographic and clinical variables
Variable Odds ratio 95% CI P value
Female sex 1.68 1.14–2.48 0.009
COPD 2.11 1.35–3.30 0.001
Sleep disturbance 3.45 2.03–5.85 0.001
Loss of appetite 2.28 1.58–4.33 0.001
CI = confidence interval, COPD = chronic obstructive pulmonary disease.were all independently associated with depressive symp-
toms (Table 2).4. Discussion
4.1. Depressive symptoms
In this study we found a very high prevalence of
depressive symptoms among a group of hospitalised, elderly
HF patients. This is consistent with findings in several other
studies. Recent studies have shown that depression is
common in HF patients with prevalence rates in outpatients
ranging from 11% to 25% [5,9,13,15,22]. In our study of
hospitalised elderly patients we found that 41% of patients
with HF reported depressive symptoms. This is comparable
to some other smaller studies that found rates of 14–77%
[4,5,8,13,15,17,22,23]. One reason for the wide range of
prevalence rates reported across studies is the use of
different definitions [23]. If depression is defined as a
clinical diagnosis, listed in the patient record as an active
problem, the prevalence will be low. Faris [15] reports that
this is an underestimation of the prevalence of depressive
symptoms. Sometimes the term depression is defined as
Fmajor depression_ as defined by DSM-IV, if this is the case,
lower incidence rates for depression are also found (9–26%)
[23]. If depression is defined as mild or moderate or as
having depressive symptoms then the incidence is much
higher. In our study, we defined depression as having
depressive symptoms.
It has also been reported in other studies, that patients
with HF suffer more frequently from moderate to severe
depression than patients with other chronic diseases (e.g.
type II diabetes, cancer). In a study of 203 older patients
with type II diabetes (mean age: 67 years) only 10% were
depressed [24]. A Dutch study of 475 patients with cancer
(mean age: 58.6 years), 19.7% had a CES-D score16
[7,25] and in a community based sample of elderly people in
the Netherlands, 15% were found to be depressed [3]. The
high rate of depressive symptoms in HF patients may be due
to the worse functional status [26,27], decrease in quality of
life [28,29] the high level of psychological distress [30,31]
and biological abnormalities [10,32].
In our study female sex, COPD, sleep disturbances and
loss of appetite were associated with depressive symptoms.
Gottlieb et al. [9] also reported that women are more likely
to experience depression. In their study among 155
outpatient HF patients 64% of the women are depressed
compared to only 44% of the men. It is also known that in
physically healthy subjects, women are twice as likely to be
diagnosed with depressive symptoms than men [7,25,33].
None of the other demographic and clinical parameters
were associated with depressive symptoms in this study
population.
COPD is a common comorbidity in HF patients and in
our study an independent risk factor associated with
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experienced by HF patients with COPD do interact with
each other and can lead to increased frequency and severity
of symptoms of HF, which in turn can lead to symptoms of
depression.
There seems to be a considerable overlap between
depressive symptoms and symptoms of HF. For example
fatigue, low mood, lost of interest in usual activities and
sleeplessness are common in both [15,18,34]. In our study,
we found that sleep disturbances and loss of appetite were
both independently associated with depressive symptoms.
The connection between these symptoms of depression in
HF patients may lie in shared mechanisms in HF and
depression. Both in HF patients and depressive patients
activation of the sympathetic nervous system, elevated
levels of cytokines, a decreased heart rate variability
(HRV) and rhythm disturbances have been described
[10,32,35–37]. For example in both patients with HF and
patients with depression a higher level of tumor necrosis
factor alpha (TNF-a) has been found [35,36], which is
linked to cardiac cachexia [35,36]. Sleep disturbance is a
symptom also often seen in both depressive and HF patients.
The shared factor in this can be the low HRV in both groups
of patients [10,18,23]. Despite the overlap in symptoms, we
found a significant difference in the amount and nature of
HF symptoms between patients with and without depressive
symptoms. In further analyses only two somatic items of the
CES-D had an overlap with the questions about HF
symptoms in the structured interview. If these two somatic
items (sleep disturbance and loss of appetite) were removed
from the CES-D, a lot of HF patients (36%) still reported
depressive symptoms (CES-D16). Furthermore for these
two items, patients with depressive symptoms score
significantly worse on both the CES-D and the structured
interview.
In conclusion: In the present study we assessed the
occurrence of depressive symptoms in elderly HF patients
and studied the relation with demographic and clinical
characteristics and HF symptoms. Depressive symptoms are
very prominent in hospitalised, elderly HF patients, espe-
cially in women and in those with more pronounced
symptomatology. Several studies have suggested that
depression and depressive symptoms in HF patients are
linked to adverse outcomes. Therefore, treatment of
depression or depressive symptoms, especially if they
continue after discharge, is important as these symptoms
may hamper successful treatment of HF and have an adverse
impact on the lives of elderly, hospitalised HF patients.Acknowledgements
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